BridgeBio Pharma (BBIO) EBITDA (2018 - 2026)
BridgeBio Pharma (BBIO) reported EBITDA of -$106.03 million for Q2 2026, compared with -$132.96 million a year earlier.
Powered by 
Analysis
BridgeBio Pharma (BBIO) EBITDA (2018 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, BridgeBio Pharma's EBITDA came in at -$492.72 million; for FY2025, it came in at -$517.98 million.
- By year, EBITDA came in at -$586.9 million in FY2024, -$600.88 million in FY2023, -$505.43 million in FY2022 and -$570.79 million in FY2021.
- Five-year quarterly EBITDA spans a low of -$224.66 million in Q4 2024 and a high of $1.94 million in Q1 2024.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$104.77 million (Q1 2026), -$138.13 million (Q4 2025) and -$143.8 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,128.06 Bn | 1,096.64 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 615.47 Bn | 534.00 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 504.80 Bn | 477.91 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 368.45 Bn | 322.83 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 298.44 Bn | 262.43 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.92 Bn | 235.60 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 236.10 Bn | 191.50 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 190.71 Bn | 164.91 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 170.16 Bn | 116.81 Bn | 10.94 Bn | 5.89 Bn |
| 10 | BridgeBio Pharma | 13.40 Bn | 10.51 Bn | 228.63 Mn | -104.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -104.10 Mn |
| Mar 31, 2026 | -102.95 Mn |
| Dec 31, 2025 | -136.68 Mn |
| Sep 30, 2025 | -142.34 Mn |
| Jun 30, 2025 | -131.53 Mn |
| Mar 31, 2025 | -101.47 Mn |
| Dec 31, 2024 | -222.60 Mn |
| Sep 30, 2024 | -190.21 Mn |
| Jun 30, 2024 | -173.97 Mn |
| Mar 31, 2024 | 1.94 Mn |
| Dec 31, 2023 | -175.83 Mn |
| Sep 30, 2023 | -156.05 Mn |
| Jun 30, 2023 | -144.46 Mn |
| Mar 31, 2023 | -124.53 Mn |
| Dec 31, 2022 | -127.57 Mn |
| Sep 30, 2022 | -127.47 Mn |
| Jun 30, 2022 | -78.59 Mn |
| Mar 31, 2022 | -171.79 Mn |
| Dec 31, 2021 | -164.09 Mn |
| Sep 30, 2021 | -149.23 Mn |
API Access
BridgeBio Pharma EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=BBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "BBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=BBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();